- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Rosetta Genomics Ltd
+ Add to WatchlistROSG:US
3.7700 USD 0.3700 10.88%As of 20:10:00 ET on 05/20/2013.
Snapshot for Rosetta Genomics Ltd (ROSG)
| Open: | 3.8000 | Day's Range: | 3.7000 - 3.9800 | Volume: | 983,109 |
|---|---|---|---|---|---|
| Previous Close: | 3.4000 | 52wk Range: | 3.0900 - 23.4300 | 1-Yr Rtn: | -45.04% |
Key Statistics for ROSG
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2012) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -34.8000 |
| Est. EPS (USD) (12/2012) | -1.5700 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 33.50 |
| Shares Outstanding (M) | 8.88 |
| 30 Day Average Volume | 301,282 |
| Price/Book (mrq) | 0.2193 |
| Price/Sale (ttm) | 3.8493 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ROSG
No data available
Company Profile & Key Executives for ROSG
Rosetta Genomics Ltd. is a biomedical company that discovers and develops diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.
| Kenneth A Berlin "Ken"President/CEO | Ranit AharonovExec VP:R&D/Head:Computational |
| Oded BiranGeneral Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ROSG News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page